We are live on
!
Find out more
SEC
Seven Eight Capital Portfolio holdings
AUM
$1.11B
1-Year Est. Return
29.48%
This Fund
S&P 500
This Quarter
Est. Return
+1.9%
1 Year Est. Return
+29.48%
3 Year Est. Return
+13.61%
5 Year Est. Return
+117.69%
10 Year Est. Return
+239.1%
AUM
$559M
AUM Growth
-$480M
(-46%)
Cap. Flow
-$438M
Cap. Flow
% of AUM
-78.37%
Top 10 Holdings %
Top 10 Hldgs %
15.86%
Holding
756
New
216
Increased
66
Reduced
143
Closed
331
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALLK
Allakos
ALLK
|
+$25.1M |
| 2 |
Merck
MRK
|
+$9.57M |
| 3 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$9.37M |
| 4 |
BridgeBio Pharma
BBIO
|
+$9.02M |
| 5 |
Marvell Technology
MRVL
|
+$7.11M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$10.5M |
| 2 |
Citigroup
C
|
+$10.5M |
| 3 |
Microsoft
MSFT
|
+$9.87M |
| 4 |
OPTU
Optimum Communications Inc
OPTU
|
+$9.41M |
| 5 |
AES
AES
|
+$7.92M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.93% |
| 2 | Consumer Discretionary | 17.95% |
| 3 | Healthcare | 12.14% |
| 4 | Communication Services | 8.7% |
| 5 | Financials | 8.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
K
301
DELISTED
Kellanova
K
| $420K | 0.08% |
+6,949
| New | +$410K |
|
302
Fidelity National Information Services
FIS
$22.1B
| $419K | 0.08% |
3,838
-62,974
| -94% | -$7.12M |
|
303
Sony
SONY
$132B
| $417K | 0.07% |
16,480
-56,530
| -77% | -$1.35M |
|
304
Cytokinetics
CYTK
$10.7B
| $409K | 0.07% |
8,979
+1,279
| +17% | +$49.4K |
|
305
United Microelectronic
UMC
$48.4B
| $408K | 0.07% |
34,906
-423,080
| -92% | -$4.71M |
|
|
HOLX
306
DELISTED
Hologic
HOLX
| $405K | 0.07% |
5,293
-39,699
| -88% | -$2.92M |
|
307
Kraft Heinz
KHC
$30.5B
| $404K | 0.07% |
11,262
-43,594
| -79% | -$1.57M |
|
308
Aflac
AFL
$63.9B
| $400K | 0.07% |
+6,847
| New | +$384K |
|
309
Quanta Services
PWR
$103B
| $399K | 0.07% |
+3,485
| New | +$402K |
|
310
Tyson Foods
TSN
$20.5B
| $399K | 0.07% |
4,578
-7,596
| -62% | -$625K |
|
|
UNVR
311
DELISTED
Univar Solutions Inc.
UNVR
| $397K | 0.07% |
+14,005
| New | +$378K |
|
|
SCHW
312
Charles Schwab
SCHW
$188B
| $387K | 0.07% |
+4,597
| New | +$372K |
|
313
Masco
MAS
$15.2B
| $385K | 0.07% |
5,485
-25,393
| -82% | -$1.64M |
|
314
Nasdaq
NDAQ
$52.9B
| $383K | 0.07% |
5,469
-52,131
| -91% | -$3.55M |
|
|
VSXY
315
Victoria's Secret
VSXY
$7.14B
| $382K | 0.07% |
+6,880
| New | +$359K |
|
316
SiteOne Landscape Supply
SITE
$4.45B
| $381K | 0.07% |
+1,573
| New | +$364K |
|
317
NOV
NOV
$6.95B
| $379K | 0.07% |
+27,946
| New | +$383K |
|
318
Valvoline
VVV
$4.72B
| $370K | 0.07% |
9,920
-13,551
| -58% | -$473K |
|
319
Ally Financial
ALLY
$13.6B
| $367K | 0.07% |
7,701
+960
| +14% | +$47.5K |
|
320
Ingersoll Rand
IR
$34.9B
| $367K | 0.07% |
5,936
-21,146
| -78% | -$1.2M |
|
321
Schrodinger
SDGR
$1.23B
| $367K | 0.07% |
10,543
+5,829
| +124% | +$266K |
|
|
SWCH
322
DELISTED
Switch, Inc. Class A Common Stock
SWCH
| $364K | 0.07% |
12,708
-111,527
| -90% | -$2.91M |
|
323
Air Products & Chemicals
APD
$65.7B
| $363K | 0.07% |
+1,193
| New | +$350K |
|
324
AutoNation
AN
$7.13B
| $362K | 0.06% |
3,097
-1,838
| -37% | -$221K |
|
325
Chevron
CVX
$366B
| $360K | 0.06% |
+3,064
| New | +$348K |
|
Similar funds
PP
ECM
GCAC
CAM
D
GFS
FTIS
AIA
Seven Eight Capital's Q4 2021 Portfolio in Review
As of Q4 2021, Seven Eight Capital held 756 positions worth $559M, down 46% from $1.04B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Seven Eight Capital withdrew a net $438M in Q4 2021, closing 331 positions and reducing 143 holdings. Its most notable exit was Bristol-Myers Squibb, an estimated $10.5M position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 23% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Seven Eight Capital opened a new position in Allakos worth $3M.
- Seven Eight Capital's largest Q4 2021 buy was Allakos: 306,723 shares worth $3M.
- Seven Eight Capital added most to Mimecast Limited in Q4 2021, an estimated $6.07M increase.
- Seven Eight Capital's biggest Q4 2021 reduction was Fidelity National Information Services, cutting an estimated $7.12M.
- Seven Eight Capital fully exited Bristol-Myers Squibb in Q4 2021, selling an estimated $10.5M.
- Seven Eight Capital's ten largest holdings make up 16% of its $559M portfolio in Q4 2021.
- Seven Eight Capital opened 216 new positions and closed 331 in Q4 2021.
- Seven Eight Capital's portfolio value fell 46% quarter-over-quarter to $559M.
Based on Seven Eight Capital's 13F filing for Q4 2021, filed 14 Feb 2022.